眼部和全身性疾病的高光谱视网膜成像生物标志物。

Hyperspectral retinal imaging biomarkers of ocular and systemic diseases.

作者信息

Saeed Abera, Hadoux Xavier, van Wijngaarden Peter

机构信息

Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, 3002, VIC, Australia.

Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, 3002, VIC, Australia.

出版信息

Eye (Lond). 2025 Mar;39(4):667-672. doi: 10.1038/s41433-024-03135-9. Epub 2024 May 22.

DOI:10.1038/s41433-024-03135-9

PMID:38778136

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11885810/

Abstract

Hyperspectral imaging is a frontier in the field of medical imaging technology. It enables the simultaneous collection of spectroscopic and spatial data. Structural and physiological information encoded in these data can be used to identify and localise typically elusive biomarkers. Studies of retinal hyperspectral imaging have provided novel insights into disease pathophysiology and new ways of non-invasive diagnosis and monitoring of retinal and systemic diseases. This review provides a concise overview of recent advances in retinal hyperspectral imaging.

摘要

高光谱成像是医学成像技术领域的一个前沿领域。它能够同时收集光谱数据和空间数据。这些数据中编码的结构和生理信息可用于识别和定位通常难以捉摸的生物标志物。视网膜高光谱成像研究为疾病病理生理学提供了新的见解，以及视网膜和全身性疾病的非侵入性诊断和监测的新方法。本文综述简要概述了视网膜高光谱成像的最新进展。